Back to all Representative Matters
Jun 6, 2019

Feronia Inc. Completes US$19.3 Million Private Placement and Debt Settlement

Richard M. Kimel and Amy Marcen-Gaudaur

Feronia Inc. (TSXV: FRN) (“Feronia”) recently completed a US$19.3 million private placement of common shares issued to existing shareholders Straight KKM 2 Limited ("KKM"), CDC Group plc (“CDC”) and Golden Oil Holdings Limited at an issuance price of C$0.075 per share. Based on a fixed exchange rate of C$1.344:US$1.00, as set out in the applicable subscription agreements, Feronia issued an aggregate of 346,062,202 common shares, including 202,702,203 common shares issued in settlement of outstanding short-term debt provided by KKM and CDC in the aggregate amount of approximately US$11.3 million.

Feronia is an agribusiness operating in the Democratic Republic of the Congo. The company uses modern agricultural practices to operate and develop its three palm oil plantations, the first of which was established in 1911. Feronia is committed to sustainable agriculture, environmental protection and providing support for local communities.

The Aird & Berlis LLP team representing Feronia was led by Richard Kimel and included Amy Marcen-Gaudaur and Clair Affleck-Jacques.

Areas of Expertise

Related Representative Matters

Representative Matters
Nextleaf Solutions Ltd. Completes Acquisition of Licensed Processor Melanie Cole, Alicia McKeag, Barbara Worndl and Saam Nainifard Aug 04, 2020 Nextleaf Solutions Ltd., an innovative Canadian cannabis extractor, recently completed the acquis... Nextleaf Solutions Ltd., an innovative Canadian cannabis extractor, recently completed the acquisition of all of the issued and outstanding shares of Nextleaf Labs Ltd., a company that holds Health Canada standard processing and research licenses under the Cannabis Act (Canada).
Representative Matters
MediPharm Labs Completes $37.8 Million Private Placement Melanie Cole, Amy Marcen-Gaudaur, Meredith McCann and Aaron Collins Jun 22, 2020 MediPharm Labs Corp., a global leader in specialized, research-driven pharmaceutical-quality cann... MediPharm Labs Corp., a global leader in specialized, research-driven pharmaceutical-quality cannabis extraction, distillation and derivative products, recently completed a private placement with an institutional investor for aggregate gross proceeds of $37,822,500.
Representative Matters
Champignon Brands Completes $15 Million Bought Deal Private Placement Jeffrey K. Merk, Melanie Cole, Russell J. Sanders and Francesco Gucciardo Jun 11, 2020 Aird & Berlis advised Champignon Brands Inc., a ketamine clinic operator, psychedelic medicine IP... Aird & Berlis advised Champignon Brands Inc., a ketamine clinic operator, psychedelic medicine IP aggregator and novel drug discoverer, in connection with its $15 million bought deal private placement.